Lung Ca Flashcards

1
Q

Primary lung toumours: the majority are…

A

95% are bronchial carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

common sites for lung Ca to metastasise

A

kidney, prostate, breast, bone, gastrointestinal tract, cervix and ovary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lung cancer subtypes and frequency

A

non-small cell 85%

3 main subtypes of non-small cell lung cancer (NSCL) :

  • 1. Squamous cell cancer 42%
  • 2. Adenocarcinoma 39%
    1. Large cell lung carcinoma 8%
    1. Carcinoid 7%
    1. Alveolar cell carcinoma: not related to smoking, ++sputum

Small Cell 15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

features of squamous cell lung ca

A

typically central

associated with ectopic PTH secretion –> hypercalcaemia

strongly associated with finger clubbing

hypertrophic pulmonary osteoarthropathy (HPOA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

features of adenocarcinoma

A
  • most common type in non-smokers, although the majority of patients who develop lung adenocarcinoma are smokers
  • typically located on the lung periphery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NSCLCa management

A
  1. only 20% suitable for surgery
  2. mediastinoscopy performed prior to surgery as CT does not always show mediastinal lymph node involvement
  3. curative or palliative radiotherap
  4. y

poor response to chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

paraneoplastic features of small cell

A
  1. ADH
  2. ACTH - not typical Cushingoid, hypertension, hyperglycaemia, hypokalaemia, alkalosis and muscle weakness are more common than buffalo hump etc
  3. Lambert-Eaton syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

paraneoplastic features of squamous cell Ca

A
  • PTH-rp>> HyperCa
  • clubbing
  • hypertrophic pulmonary osteoarthropathy (HPOA)
  • hyperthyroidism due to ectopic TS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

paraneoplastic features of adenocarcinom

A

gynaecomastia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lung Ca risk factors

A
  1. Smoking: increases risk of lung ca by a factor of 10
  2. asbestos - increases risk of lung ca by a factor of 5.
  3. Smoking and asbestos are synergistic= 50 times increased risk
  4. arsenic
  5. radon
  6. nickel
  7. chromate
  8. aromatic hydrocarbon
  9. cryptogenic fibrosing alveolitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

is coal dust a risk factor for lung Ca?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

feautres of Small Cell Lung Ca

A

Features

  1. usually central
  2. arise from APUD cells
    • Amine - high amine content
    • Precursor Uptake - high uptake of amine precursors
    • Decarboxylase - high content of the enzyme decarboxylase
  3. associated with ectopic ADH, ACTH secretion
    • ADH –> hyponatraemia
    • ACTH –> Cushing’s syndrome
  4. ACTH secretion can cause bilateral adrenal hyperplasia, the high levels of cortisol can lead to hypokalaemic alkalosis
  5. Lambert-Eaton syndrome: antibodies to voltage gated calcium channels causing myasthenic like syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mx for small cell lung ca

A
  • usually metastatic disease by time of diagnosis
  • surgery: only for debulking
  • most with limited disease now receive a combination of chemotherapy and radiotherapy

patients with more extensive disease are offered palliative chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Local tumour effects

A
  1. Persistent cough, or change in usual cough
  2. Haemoptysis
  3. Chest pain (suggests chest wall or pleural involvement)
  4. Unresolving pneumonia or lobar collapse
  5. Unexplained dyspnoea (bronchial narrowing or obstruction)
  6. Wheeze or stridor
  7. Shoulder pain (diaphragm involvement)
  8. Pleural effusion (direct tumour extension or pleural metastases)
  9. Hoarse voice (tumour invasion of the left recurrent laryngeal nerve)
  10. Dysphagia
  11. Raised hemi-diaphragm (phrenic nerve paralysis)
  12. SVCO
  13. Horner’s syndrome (meiosis, ptosis, enopthalmos, anhidrosis) due to apical or Pancoast’s tumour
  14. P

ancoast’s tumours can directly invade the sympathetic chain, brachial plexus, and rib→weakness of small muscles of the hand—C5/6, T1 motor loss, and shoulder pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Paraneoplastic syndromes

A
  1. Cachexia and wasting
  2. Clubbing (up to 29% of pts; any cell type, more common in squamous and adenocarcinoma)
  3. Gynaecomastia
  4. SIADH (mainly SCLC) in up to 15% of pts
  5. Ectopic ACTH (Cushing’s syndrome, but due to rapid development biochemical changes predominate, mainly SCLC) in 2–5% of pts
  6. Hypertrophic pulmonary osteo-arthropathy (HPOA, often in association with clubbing, any cell type; more common in squamous and adenocarcinoma)
  7. Lambert–Eaton myasthenic syndrome (or LEMS)—with SCLC. Affects proximal limbs and trunk, with autonomic involvement (dry mouth, constipation, erectile failure) and hyporeflexia (although reflexes return on exercising the affected muscle group), and only a slight response to edrophonium. Symptoms may predate lung cancer by up to 4 years
  8. Cerebellar syndrome (usually SCLC)
  9. Limbic encephalitis (SCLC, also breast, testicular, other cancers. Occurs within 4 years of dx of cancer. Personality change, seizures, depression, sub-acute onset confusion and short-term memory loss. Dxd by pathological or radiological involvement of limbic system. Anti-Hu antibodies positive in 50% if associated with lung cancer.)
  10. Glomerulonephritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

has there been improvement of outcomes with chemotherapy?

A

No,

There has been no clear improvement in clinical outcomes with
chemotherapy drugs in recent years (‘plateau’ reached)

17
Q

New therapies?

A

• Need for new therapies with proven clinical benefit and
improved tolerability
– targeted agents alone or in combination
– immunotherapy
– tailored chemotherapy

  • Drugs targeting EGFR and VEGF already approved
  • New generation agents likely to improve EGFR targeting

• Other targets
– VEGFR
– IGF1R?

18
Q

Mesothelioma

epidemiology

pathology

A

most common between 50-70y/o males

arises from mesothelial cells of pleura (or rarely peritoneum)

Asbestos exposure responsible for >85%, with a delay between exposure and manifestation of >30years

survival from presentation is 8-14 months